|
FAM117A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63091762317435E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
1.900490E-03 |
| Normal-vs-Stage3 |
2.78409517662226E-11 |
| Normal-vs-Stage4 |
3.40572015034013E-12 |
| Stage1-vs-Stage2 |
1.513660E-02 |
| Stage1-vs-Stage3 |
9.164400E-01 |
| Stage1-vs-Stage4 |
1.725440E-01 |
| Stage2-vs-Stage3 |
1.812100E-02 |
| Stage2-vs-Stage4 |
3.540600E-03 |
| Stage3-vs-Stage4 |
2.307000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-15 |
| Normal-vs-AfricanAmerican |
2.656300E-03 |
| Normal-vs-Asian |
1.68440039693962E-10 |
| Caucasian-vs-AfricanAmerican |
1.731050E-01 |
| Caucasian-vs-Asian |
7.837400E-01 |
| AfricanAmerican-vs-Asian |
3.855200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.82596210058273E-13 |
| Normal-vs-Female |
1.68465241756621E-12 |
| Male-vs-Female |
8.980600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62758695410048E-12 |
| Normal-vs-Age(41-60Yrs) |
1.90549798162465E-11 |
| Normal-vs-Age(61-80Yrs) |
7.40509986663085E-10 |
| Normal-vs-Age(81-100Yrs) |
5.215600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.330300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.855230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.608800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.063400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.599800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.349800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.416000E-04 |
| Classical-VS-Follicular |
1.581800E-04 |
| Classical-VS-Other |
6.251200E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
2.40830000386438E-08 |
| Tall-VS-Other |
2.836200E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
7.939800E-01 |
| Follicular-VS-Normal |
3.90239999999986E-05 |
| Other-VS-Normal |
2.129400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03919983729384E-10 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.27760000001587E-06 |
|
|
